LEMAITRE VASCULAR INC

LeMaitre Vascular, Inc. announced it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market closes. The company has scheduled a conference call for 5:00 PM EDT on the same day to discuss the results, business highlights, and company outlook. Interested parties can register online to access the live call or view the audio webcast via replay.

LeMaitre Vascular, Inc. announced that its management will participate in two investor conferences in June. The company will hold a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026, and present at the Goldman Sachs Annual Global Healthcare Conference on June 10, 2026.

LeMaitre Vascular, Inc. announced that its management will present at the Bank of America Healthcare Conference on May 13, 2026, at 5:15 PM PT. The company is a provider of devices, implants, and services for the treatment of peripheral vascular disease, focusing on vascular surgeons.

LeMaitre Vascular reported strong financial results for the first quarter of 2026, with net sales increasing by 11.2% and net income surging by 42.4% year-over-year. Diluted earnings per share also saw a substantial rise of 41.7%. The company also increased its cash dividend per common share by 25% to $0.25.

LeMaitre Vascular reported strong Q1 2026 financial results, with sales increasing 11% to $66.6 million and diluted EPS growing 42% to $0.68. The company also announced a quarterly dividend of $0.25 per share and provided increased guidance for Q2 and the full year 2026, projecting continued sales and EPS growth. Additionally, a $100 million share repurchase program remains active.

LeMaitre Vascular, Inc. announced it will release its first quarter 2026 financial results on Tuesday, May 5, 2026, after the market closes. The company has scheduled a conference call for 5:00 PM EDT on the same day to discuss the results, business highlights, and company outlook. Investors can register online to access the live call or view the audio webcast live or via replay.

LeMaitre Vascular, Inc. announced that Bridget Ross will not stand for re-election as a Class II director at the 2026 Annual Meeting, effective June 2, 2026. Her decision is not related to any disagreement with the company. Concurrently, David B. Roberts, a current Class I director, has been nominated to stand for election as a Class II director, and will resign his Class I position if elected, to rebalance the board.

LeMaitre Vascular, Inc. announced that Bridget Ross will not stand for re-election as a Class II director at the 2026 Annual Meeting, with her term concluding on June 2, 2026. Her decision is not related to any disagreement with the company. To rebalance the Board classes, David B. Roberts, currently a Class I director, has been nominated to stand for election as a Class II director and will conditionally resign from his Class I position upon election. Following these changes, the Board will comprise seven members.